| Dr Jeffrey M Hirschberg, MD | |
|
2180 Main St, Wailuku, HI 96793-1625 | |
| (808) 242-6464 | |
| (808) 242-4292 |
| Full Name | Dr Jeffrey M Hirschberg |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 2180 Main St, Wailuku, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184821761 | NPI | - | NPPES |
| MD-15316 | Other | HI | HAWAII LIC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD-15316 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pali Momi Medical Center | Aiea, HI | Hospital |
| Adventist Health Castle | Kailua, HI | Hospital |
| Wahiawa General Hospital | Wahiawa, HI | Hospital |
| The Queens Medical Center | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hawaii Hospital Physicians Inc | 3173413275 | 14 |
| Inpatient Medicine Services Llc | 5890833313 | 10 |
News Archive
Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.
Janssen R&D Ireland (Janssen) announced today that two Phase 3 trials are recruiting patients to examine the efficacy and safety of the NS3/4A protease inhibitor simeprevir in combination with the nucleotide inhibitor sofosbuvir for the treatment of chronic genotype 1 hepatitis C virus (HCV) infection in treatment-naive and treatment-experienced patients with and without cirrhosis.
A compact, self-contained sensor recorded and transmitted brain activity data wirelessly for more than a year in early stage animal tests, according to a study funded by the National Institutes of Health.
Catholic Bishops have been speaking out against health care reform proposals in recent weeks, after largely embracing the overhaul's goals last month as a continuation of their efforts to secure health care for the poor, The New York Times reports.
› Verified 5 days ago
| Entity Name | Hawaii Hospital Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427153576 PECOS PAC ID: 3173413275 Enrollment ID: O20040319000808 |
News Archive
Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.
Janssen R&D Ireland (Janssen) announced today that two Phase 3 trials are recruiting patients to examine the efficacy and safety of the NS3/4A protease inhibitor simeprevir in combination with the nucleotide inhibitor sofosbuvir for the treatment of chronic genotype 1 hepatitis C virus (HCV) infection in treatment-naive and treatment-experienced patients with and without cirrhosis.
A compact, self-contained sensor recorded and transmitted brain activity data wirelessly for more than a year in early stage animal tests, according to a study funded by the National Institutes of Health.
Catholic Bishops have been speaking out against health care reform proposals in recent weeks, after largely embracing the overhaul's goals last month as a continuation of their efforts to secure health care for the poor, The New York Times reports.
› Verified 5 days ago
| Entity Name | Inpatient Medicine Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013147065 PECOS PAC ID: 5890833313 Enrollment ID: O20091103000494 |
News Archive
Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.
Janssen R&D Ireland (Janssen) announced today that two Phase 3 trials are recruiting patients to examine the efficacy and safety of the NS3/4A protease inhibitor simeprevir in combination with the nucleotide inhibitor sofosbuvir for the treatment of chronic genotype 1 hepatitis C virus (HCV) infection in treatment-naive and treatment-experienced patients with and without cirrhosis.
A compact, self-contained sensor recorded and transmitted brain activity data wirelessly for more than a year in early stage animal tests, according to a study funded by the National Institutes of Health.
Catholic Bishops have been speaking out against health care reform proposals in recent weeks, after largely embracing the overhaul's goals last month as a continuation of their efforts to secure health care for the poor, The New York Times reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey M Hirschberg, MD 98-1079 Moanalua Rd, Aiea, HI 96701-4713 Ph: (808) 485-4305 | Dr Jeffrey M Hirschberg, MD 2180 Main St, Wailuku, HI 96793-1625 Ph: (808) 242-6464 |
News Archive
Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.
Janssen R&D Ireland (Janssen) announced today that two Phase 3 trials are recruiting patients to examine the efficacy and safety of the NS3/4A protease inhibitor simeprevir in combination with the nucleotide inhibitor sofosbuvir for the treatment of chronic genotype 1 hepatitis C virus (HCV) infection in treatment-naive and treatment-experienced patients with and without cirrhosis.
A compact, self-contained sensor recorded and transmitted brain activity data wirelessly for more than a year in early stage animal tests, according to a study funded by the National Institutes of Health.
Catholic Bishops have been speaking out against health care reform proposals in recent weeks, after largely embracing the overhaul's goals last month as a continuation of their efforts to secure health care for the poor, The New York Times reports.
› Verified 5 days ago
Pamela D. Hope, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 55 Maui Lani Pkwy, Wailuku, HI 96793 Phone: 808-243-6050 | |
Dr. Joseph K Kamaka Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 99 South Market Street, Wailuku, HI 96793 Phone: 808-244-5551 Fax: 808-242-0058 | |
Russell Garn, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2180 Main St, Wailuku, HI 96793 Phone: 808-242-6464 Fax: 808-984-7434 | |
Margot J. Crandall, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-244-9056 | |
Dr. Nolan Arruda, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2180 Main St, Wailuku, HI 96793 Phone: 808-242-6464 Fax: 808-243-2344 | |
Stephen A. Bangle, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 80 Mahalani St, Wailuku, HI 96793 Phone: 808-243-6000 | |
Drosie E. Rosaro, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Maui Lani Pkwy, Wailuku, HI 96793 Phone: 808-243-6050 |